Acciones Innovus Pharmaceuticals Inc Other OTC
Acciones
US45778V1061
Farmacéuticos
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,82 % | 734 mil M | |
+32,85 % | 591 mil M | |
-7,31 % | 350 mil M | |
+14,23 % | 315 mil M | |
+0,86 % | 276 mil M | |
+14,40 % | 238 mil M | |
+9,23 % | 206 mil M | |
-6,13 % | 204 mil M | |
+4,51 % | 161 mil M |